![MYC-driven epigenetic reprogramming favors the onset of tumorigenesis by inducing a stem cell-like state | Nature Communications MYC-driven epigenetic reprogramming favors the onset of tumorigenesis by inducing a stem cell-like state | Nature Communications](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41467-018-03264-2/MediaObjects/41467_2018_3264_Fig1_HTML.png)
MYC-driven epigenetic reprogramming favors the onset of tumorigenesis by inducing a stem cell-like state | Nature Communications
![Frontiers | EZH2 Inhibition Compromises α4-1BB-Mediated Antitumor Efficacy by Reducing the Survival and Effector Programming of CD8+ T Cells | Immunology Frontiers | EZH2 Inhibition Compromises α4-1BB-Mediated Antitumor Efficacy by Reducing the Survival and Effector Programming of CD8+ T Cells | Immunology](https://www.frontiersin.org/files/Articles/770080/fimmu-12-770080-HTML-r1/image_m/fimmu-12-770080-g001.jpg)
Frontiers | EZH2 Inhibition Compromises α4-1BB-Mediated Antitumor Efficacy by Reducing the Survival and Effector Programming of CD8+ T Cells | Immunology
![JCM | Free Full-Text | Impact of SARS-CoV-2 Lockdown on Glycaemic Control: A Retrospective Observational Cohort Study in a Tertiary Setting | HTML JCM | Free Full-Text | Impact of SARS-CoV-2 Lockdown on Glycaemic Control: A Retrospective Observational Cohort Study in a Tertiary Setting | HTML](https://www.mdpi.com/jcm/jcm-10-04098/article_deploy/html/images/jcm-10-04098-g001.png)
JCM | Free Full-Text | Impact of SARS-CoV-2 Lockdown on Glycaemic Control: A Retrospective Observational Cohort Study in a Tertiary Setting | HTML
![Frontiers | New Perspectives for Resistance to PARP Inhibitors in Triple-Negative Breast Cancer | Oncology Frontiers | New Perspectives for Resistance to PARP Inhibitors in Triple-Negative Breast Cancer | Oncology](https://www.frontiersin.org/files/MyHome%20Article%20Library/578095/578095_Thumb_400.jpg)
Frontiers | New Perspectives for Resistance to PARP Inhibitors in Triple-Negative Breast Cancer | Oncology
![Frontiers | New Perspectives for Resistance to PARP Inhibitors in Triple-Negative Breast Cancer | Oncology Frontiers | New Perspectives for Resistance to PARP Inhibitors in Triple-Negative Breast Cancer | Oncology](https://www.frontiersin.org/files/Articles/578095/fonc-10-578095-HTML/image_m/fonc-10-578095-g001.jpg)
Frontiers | New Perspectives for Resistance to PARP Inhibitors in Triple-Negative Breast Cancer | Oncology
![PDF) Two sides of the same coin? Unraveling subtle differences between human embryonic and induced pluripotent stem cells by Raman spectroscopy PDF) Two sides of the same coin? Unraveling subtle differences between human embryonic and induced pluripotent stem cells by Raman spectroscopy](https://i1.rgstatic.net/publication/321351370_Two_sides_of_the_same_coin_Unraveling_subtle_differences_between_human_embryonic_and_induced_pluripotent_stem_cells_by_Raman_spectroscopy/links/5a1ea9b2a6fdccc6b7f8a5f2/largepreview.png)
PDF) Two sides of the same coin? Unraveling subtle differences between human embryonic and induced pluripotent stem cells by Raman spectroscopy
![MYC-driven epigenetic reprogramming favors the onset of tumorigenesis by inducing a stem cell-like state | Nature Communications MYC-driven epigenetic reprogramming favors the onset of tumorigenesis by inducing a stem cell-like state | Nature Communications](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41467-018-03264-2/MediaObjects/41467_2018_3264_Fig2_HTML.png)
MYC-driven epigenetic reprogramming favors the onset of tumorigenesis by inducing a stem cell-like state | Nature Communications
![Exploring Knowledge Sharing in Sea-Land Logistics Networks: Lessons from the Port of Genoa | Cairn.info Exploring Knowledge Sharing in Sea-Land Logistics Networks: Lessons from the Port of Genoa | Cairn.info](https://www.cairn.info/vign_rev/JIE/JIE_033.jpg)
Exploring Knowledge Sharing in Sea-Land Logistics Networks: Lessons from the Port of Genoa | Cairn.info
![IJMS | Free Full-Text | What Do We Have to Know about PD-L1 Expression in Prostate Cancer? A Systematic Literature Review. Part 5: Epigenetic Regulation of PD-L1 | HTML IJMS | Free Full-Text | What Do We Have to Know about PD-L1 Expression in Prostate Cancer? A Systematic Literature Review. Part 5: Epigenetic Regulation of PD-L1 | HTML](https://www.mdpi.com/ijms/ijms-22-12314/article_deploy/html/images/ijms-22-12314-g001.png)